Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First molecular-based detection study of Leishmania infantum in the Tapirapé indigenous population in the Brazilian Amazon.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas·2022
Same author

Antibacterial bioadhesive layer-by-layer coatings for orthopedic applications.

Journal of materials chemistry. B·2020
Same author

Intake, digestibility, ingestive behavior, and nitrogen balance of goats fed with diets containing residue from tamarind fruit.

Tropical animal health and production·2019
Same author

Fluoranthene Biodegradation by Serratia sp. AC-11 Immobilized into Chitosan Beads.

Applied biochemistry and biotechnology·2019
Same author

Flaxseed improves embryo production in Boer goats.

Theriogenology·2019
Same author

Optimization of silver-containing bioglass nanoparticles envisaging biomedical applications.

Materials science & engineering. C, Materials for biological applications·2018
Same journal

Diallel crosses for resistance to Macrophomina phaseolina and Thanatephorus cucumeris on cowpea.

Genetics and molecular research : GMR·2017
Same journal

Diversity among elephant grass genotypes using Bayesian multi-trait model.

Genetics and molecular research : GMR·2017
Same journal

Coupled transcript and metabolite identification: insights on induction and synthesis of resveratrol in peanut, wild relatives and synthetic allotetraploid.

Genetics and molecular research : GMR·2017
Same journal

Estimates of genetics and phenotypics parameters for the yield and quality of soybean seeds.

Genetics and molecular research : GMR·2017
Same journal

In silico modeling and characterization of phytoparasitic nematodes translationally-controlled tumor proteins.

Genetics and molecular research : GMR·2017
Same journal

Molecular identification of variety purity in a cotton hybrid with unknown parentage using DNA-SSR markers.

Genetics and molecular research : GMR·2017
See all related articles

Related Experiment Video

Updated: May 17, 2026

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
13:47

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Published on: June 3, 2018

GSTM1 polymorphism in patients with primary open-angle glaucoma.

A M Barbosa1, A B Frare, N B Costa

  • 1Curso de Biologia, Pontifícia Universidade Católica de Goiás, Goiânia, GO, Brasil. andreiamarcelino_@hotmail.com

Genetics and Molecular Research : GMR
|October 20, 2012
PubMed
Summary
This summary is machine-generated.

Primary open-angle glaucoma (POAG) patients showed a higher frequency of the GSTM1 gene null polymorphism. However, this difference was not statistically significant, possibly due to the small sample size in this glaucoma study.

More Related Videos

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

Related Experiment Videos

Last Updated: May 17, 2026

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
13:47

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Published on: June 3, 2018

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

Area of Science:

  • Ophthalmology
  • Genetics
  • Biochemistry

Background:

  • Primary open-angle glaucoma (POAG) is a leading cause of irreversible blindness globally, affecting millions.
  • Glaucoma involves retinal ganglion cell loss and optic nerve damage, leading to visual field loss.
  • Glutathione S-transferases (GST) are crucial phase-II drug-metabolizing enzymes involved in detoxification and oxidative stress management.

Purpose of the Study:

  • To investigate the association between the GSTM1 gene null polymorphism and primary open-angle glaucoma (POAG).
  • To explore the potential role of GSTM1 in the pathogenesis of POAG.

Main Methods:

  • DNA samples were collected from 25 POAG patients and 25 healthy controls.
  • Polymerase Chain Reaction (PCR) amplification was used to analyze the presence or absence of the GSTM1 gene.
  • The frequency of the GSTM1 gene null polymorphism was compared between the POAG group and the control group.

Main Results:

  • The GSTM1 gene null polymorphism was observed in 14 out of 25 POAG patients (56%).
  • In the control group, 8 out of 25 individuals (32%) presented the GSTM1 gene null polymorphism.
  • While POAG patients exhibited a higher frequency of the GSTM1 null polymorphism, the difference was not statistically significant (P = 0.0874).

Conclusions:

  • The study suggests a potential, though not statistically significant, association between the GSTM1 gene null polymorphism and POAG.
  • The observed lack of significance may be attributed to the limited sample size.
  • Further research with larger cohorts is warranted to clarify the role of GSTM1 in POAG pathogenesis.